EA201990602A2 - COMBINATIONS OF PALMITOYLETHANOLAMIDE FOR THE TREATMENT OF CHRONIC PAIN - Google Patents
COMBINATIONS OF PALMITOYLETHANOLAMIDE FOR THE TREATMENT OF CHRONIC PAINInfo
- Publication number
- EA201990602A2 EA201990602A2 EA201990602A EA201990602A EA201990602A2 EA 201990602 A2 EA201990602 A2 EA 201990602A2 EA 201990602 A EA201990602 A EA 201990602A EA 201990602 A EA201990602 A EA 201990602A EA 201990602 A2 EA201990602 A2 EA 201990602A2
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- palmitoylethanolamide
- treatment
- chronic pain
- combinations
- combination
- Prior art date
Links
- 208000000094 Chronic Pain Diseases 0.000 title abstract 2
- 208000002193 Pain Diseases 0.000 title abstract 2
- 229950007031 palmidrol Drugs 0.000 title abstract 2
- HXYVTAGFYLMHSO-UHFFFAOYSA-N palmitoyl ethanolamide Chemical compound CCCCCCCCCCCCCCCC(=O)NCCO HXYVTAGFYLMHSO-UHFFFAOYSA-N 0.000 title abstract 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 abstract 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 abstract 2
- 208000017667 Chronic Disease Diseases 0.000 abstract 1
- DJJCXFVJDGTHFX-UHFFFAOYSA-N Uridinemonophosphate Natural products OC1C(O)C(COP(O)(O)=O)OC1N1C(=O)NC(=O)C=C1 DJJCXFVJDGTHFX-UHFFFAOYSA-N 0.000 abstract 1
- 229930003427 Vitamin E Natural products 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 abstract 1
- 210000000653 nervous system Anatomy 0.000 abstract 1
- 230000001717 pathogenic effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 238000009097 single-agent therapy Methods 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 238000002636 symptomatic treatment Methods 0.000 abstract 1
- 208000011580 syndromic disease Diseases 0.000 abstract 1
- 229960003080 taurine Drugs 0.000 abstract 1
- DJJCXFVJDGTHFX-XVFCMESISA-N uridine 5'-monophosphate Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(O)=O)O[C@H]1N1C(=O)NC(=O)C=C1 DJJCXFVJDGTHFX-XVFCMESISA-N 0.000 abstract 1
- 229940046009 vitamin E Drugs 0.000 abstract 1
- 235000019165 vitamin E Nutrition 0.000 abstract 1
- 239000011709 vitamin E Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Изобретение относится к области медицины, фармакологии, а именно к комбинации пальмитоилэтаноламида и по меньшей мере одного вещества, выбранного из группы, включающей уридинмонофосфат, таурин и витамин E, или их фармацевтически приемлемых солей. Такая комбинация применяется для патогенетического и симптоматического лечения в виде монотерапии и в составе комплексной терапии хронической боли, заболеваний и синдромов нервной системы различного происхождения.The invention relates to medicine, pharmacology, and in particular to a combination of palmitoylethanolamide and at least one substance selected from the group consisting of uridine monophosphate, taurine and vitamin E, or their pharmaceutically acceptable salts. This combination is used for pathogenetic and symptomatic treatment in the form of monotherapy and as part of the complex treatment of chronic pain, diseases and syndromes of the nervous system of various origins.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2018113299A RU2701720C1 (en) | 2018-04-12 | 2018-04-12 | Combinations of palmitoylethanolamide for treating chronic pain |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| EA201990602A2 true EA201990602A2 (en) | 2019-10-31 |
| EA201990602A3 EA201990602A3 (en) | 2019-12-30 |
| EA038052B1 EA038052B1 (en) | 2021-06-29 |
Family
ID=68170703
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA201990602A EA038052B1 (en) | 2018-04-12 | 2019-03-27 | Combination comprising palmitoylethanolamide for treating chronic pain |
Country Status (2)
| Country | Link |
|---|---|
| EA (1) | EA038052B1 (en) |
| RU (1) | RU2701720C1 (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GR20200100479A (en) * | 2020-08-13 | 2022-03-09 | Pharma Unimedis Ike, | Diatary supplement for the prevention and/or treatment of pain and/or neropathies |
| IT202200006080A1 (en) * | 2022-03-28 | 2023-09-28 | Laboratorio Della Farm S P A | Oral solid composition for the management of neuropathic, osteo-articular, gynecological, post-surgical pain and mitochondrial trophism |
| IT202200016737A1 (en) * | 2022-08-04 | 2024-02-04 | B2Pharma S R L | Bioavailable association of analgesic and/or neurotrophic active ingredients |
| IT202300007314A1 (en) * | 2023-04-14 | 2024-10-14 | Soal Pharma Srl | Food supplement for the treatment of fibromyalgia |
| WO2025186837A1 (en) * | 2024-03-08 | 2025-09-12 | Validus Lifesciences Pvt. Ltd. | A synergistic bioactive composition for controlling neuromuscular pain and repairing nerve damage |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080288019A1 (en) * | 2007-01-31 | 2008-11-20 | Adam Heller | Electrochemical management of pain |
-
2018
- 2018-04-12 RU RU2018113299A patent/RU2701720C1/en active
-
2019
- 2019-03-27 EA EA201990602A patent/EA038052B1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EA038052B1 (en) | 2021-06-29 |
| EA201990602A3 (en) | 2019-12-30 |
| RU2701720C1 (en) | 2019-10-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201990602A2 (en) | COMBINATIONS OF PALMITOYLETHANOLAMIDE FOR THE TREATMENT OF CHRONIC PAIN | |
| EA202190661A1 (en) | PHARNESOID X-RECEPTOR AGONISTS FOR DISEASE TREATMENT | |
| EA201890725A1 (en) | PHARNESIDE X-RECEPTOR AGONISTS AND THEIR APPLICATION | |
| EA202090573A1 (en) | COMPOSITIONS OF NIRAPARIBA | |
| EA202090019A1 (en) | SPYROCYCLIC INDOLINS AS IL-17 MODULATORS | |
| NI201900099A (en) | INDOLINE DERIVATIVES SUBSTITUTE AS INHIBITORS OF DENGUE VIRAL REPLICATION | |
| ECSP19083621A (en) | INDOLINE DERIVATIVES SUBSTITUTE AS INHIBITORS OF DENGUE VIRAL REPLICATION | |
| MX2019012818A (en) | METHODS TO IMPROVE MEMORY AND COGNITION AND FOR THE TREATMENT OF MEMORY AND COGNITIVE DISORDERS. | |
| EA201792214A1 (en) | COMPOUNDS OF SUBSTITUTE QUINAZOLINE | |
| ECSP19070413A (en) | INDOLINE DERIVATIVES SUBSTITUTE AS INHIBITORS OF DENGUE VIRAL REPLICATION | |
| EA201890454A1 (en) | PYRROPHYRIMIDINE NUCLEOSIDE AND THEIR ANALOGUES THAT CAN BE USED AS ANTI-VIRUS MEANS | |
| MX389354B (en) | PEPTIDOMIMETIC MACROCYCLES AND FORMULATIONS THEREOF. | |
| ECSP19083640A (en) | INDOLINE DERIVATIVES SUBSTITUTE AS INHIBITORS OF DENGUE VIRAL REPLICATION | |
| ECSP18073366A (en) | INDOLINE DERIVATIVES SUBSTITUTE AS INHIBITORS OF DENGUE VIRAL REPLICATION | |
| ECSP18073293A (en) | INDOLINE DERIVATIVES SUBSTITUTE AS INHIBITORS OF DENGUE VIRAL REPLICATION | |
| BR112017014067A2 (en) | composition to treat diseases related to il-6 | |
| EA201791727A1 (en) | 7-BENZYL-4- (2-METHYLBENZIL) -2,4,6,7,8,9-HEXAHYDROIMIDAZO [1,2-A] PYRIDO [3,4-E] PYRIMIDIN-5 (1H) -OH, ITS ANALOGUES AND SALTS AND METHODS OF THEIR APPLICATION IN THERAPY | |
| EA201792304A1 (en) | COMBINED THERAPY FOR CANCER TREATMENT | |
| EA201992354A1 (en) | BENZOAZEPINE ANALOGUES AS INHIBITING AGENTS FOR BRUTON TYROSINKINASE | |
| EA201591701A1 (en) | COMBINATION OF ANTI-VIRAL DIRECT ACTION AND RIBAVIRIN FOR THE TREATMENT OF PATIENTS WITH HCV | |
| CO2021005797A2 (en) | Methods and formulations to treat chemotherapy-induced nausea and vomiting | |
| UY36408A (en) | PIRIDO BENZODIAZEPINA SUBSTITUTED DERIVATIVES AND ITS USE | |
| EA201792170A1 (en) | INDOLA DERIVATIVES | |
| BR112018073396A2 (en) | antagonist combination, use of a combination, method for treating cognitive disorders, compound, method for treating alzheimer's disease and pharmaceutical composition | |
| PH12014501601A1 (en) | Artemisinin-based combination therapy for treating viral mediated disease |